Skip to main content
. 2020 Jul 6;12(7):1807. doi: 10.3390/cancers12071807

Figure 3.

Figure 3

Immune-checkpoint molecules keep balance of the immune system: (A) Immunocostimulatory checkpoint receptors responsible for the enhanced immune cell proliferation, survival and activation and agonistic compound fully activates the receptor that it binds; (B) Immunoinhibitory checkpoint molecules diminish cell cytotoxic potential and prevent their antitumor functions and antagonistic compound that binds to a receptor but does not activate.